GE HealthCare Technologies (GEHC) - Stock & Dividends

GE HealthCare Technologies Inc., listed as NASDAQ:GEHC, is deeply involved in creating, producing, and promoting an array of products, services, and digital solutions for diagnostics, treatment, and patient monitoring globally, not limited to the United States and Canada. It is divided into four main sectors for effective operation: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

The Imaging branch covers a wide spectrum, from molecular imaging to various scanning technologies such as CT and MR imaging, as well as image-guided therapy, X-ray systems, and products dedicated to women's health.

Meanwhile, the Ultrasound division focuses on delivering medical devices and solutions designed for the screening, diagnosis, treatment, and monitoring of diseases across multiple clinical areas, including radiology, primary care, cardiovascular health, among others. It also features handheld ultrasound solutions and surgical visualization and guidance products.

In the realm of Patient Care Solutions, the company offers an extensive range of medical devices, consumables, services, and digital innovations. From patient monitoring to anesthesia delivery, respiratory care, electrocardiogram solutions, maternal-infant care, and various consumables, this segment caters to a broad spectrum of healthcare needs.

Lastly, the Pharmaceutical Diagnostics arm supplies a host of diagnostic agents utilized in various imaging techniques like CT, angiography, MR, and ultrasound. Its offerings include contrast media pharmaceuticals for enhancing imaging visibility, as well as molecular imaging agents and radiopharmaceuticals labeled with radioisotopes.

Originally known as GE Healthcare Holding LLC, the company assumed its present moniker, GE HealthCare Technologies Inc., in December 2022. Founded in 2022, its headquarters are situated in Chicago, Illinois. For further information, visit their official website at https://www.gehealthcare.com.